ZS Pharma, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
ZS Pharma, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$60.96 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2015-11-09
- ZS Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-09-30 was -$21.58M.
- ZS Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-06-30 was -$23.27M.
- ZS Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-03-31 was -$16.11M.
- ZS Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-12-31 was -$17.02M.
- ZS Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$49.02M.
- ZS Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$26.53M.
- ZS Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was -$7.17M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2015-09-30 | -$21.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$44.85M derived: sum of 2 quarters · filed 2015-11-09 | -$60.96M 10-Q · filed 2015-11-09 | -$77.98M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | -$23.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$39.38M 10-Q · filed 2015-08-06 | -$56.40M derived: sum of 3 quarters · filed 2015-08-06 | -$72.28M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-03-31 | -$16.11M 10-Q · filed 2015-05-11 | -$33.13M derived: sum of 2 quarters · filed 2015-05-11 | -$49.02M derived: sum of 3 quarters · filed 2015-11-09 | -$56.14M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-12-31 | -$17.02M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$32.91M derived: sum of 2 quarters · filed 2015-11-09 | -$40.03M derived: sum of 3 quarters · filed 2015-11-09 | -$49.02M 10-K · filed 2015-03-13 |
| 2014-09-30 | -$15.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$23.01M derived: sum of 2 quarters · filed 2015-11-09 | -$32.00M 10-Q · filed 2015-11-09 | -$39.52M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | -$7.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$16.11M 10-Q · filed 2015-08-06 | -$23.63M derived: sum of 3 quarters · filed 2015-08-06 | -$31.57M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | -$8.99M 10-Q · filed 2015-05-11 | -$16.51M derived: sum of 2 quarters · filed 2015-05-11 | -$24.45M derived: sum of 3 quarters · filed 2015-05-11 | |
| 2013-12-31 | -$7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$15.45M derived: sum of 2 quarters · filed 2015-03-13 | -$26.53M 10-K · filed 2015-03-13 | |
| 2013-09-30 | -$7.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$19.01M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | -$11.07M 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | -$7.17M 10-K · filed 2015-03-13 |